41
Views
133
CrossRef citations to date
0
Altmetric
Signal Transduction

Phosphoinositide 3-Kinase Catalytic Subunit Deletion and Regulatory Subunit Deletion Have Opposite Effects on Insulin Sensitivity in Mice

, , , &
Pages 1596-1607 | Received 24 Jul 2004, Accepted 29 Nov 2004, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Carlo C Campa, Elisa Ciraolo, Alessandra Ghigo, Giulia Germena & Emilio Hirsch. (2015) Crossroads of PI3K and Rac pathways. Small GTPases 6:2, pages 71-80.
Read now
Ronald W. Matheny$suffix/text()$suffix/text(), Christine M. Lynch & Luis A. Leandry. (2012) Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2. Growth Factors 30:6, pages 367-384.
Read now
Laura Braccini, Elisa Ciraolo, Fulvio Morello, Xiaoyun Lu & Emilio Hirsch. (2009) PI3K signaling: a crossroads of metabolic regulation. Expert Review of Endocrinology & Metabolism 4:4, pages 349-357.
Read now

Articles from other publishers (130)

Shreya Chakraborty & V. Devi Rajeswari. (2022) Biomedical aspects of beta-glucan on glucose metabolism and its role on primary gene PIK3R1. Journal of Functional Foods 99, pages 105296.
Crossref
Roberta Malaguarnera, Caterina Gabriele, Gianluca Santamaria, Marika Giuliano, Veronica Vella, Michele Massimino, Paolo Vigneri, Giovanni Cuda, Marco Gaspari & Antonino Belfiore. (2022) Comparative proteomic analysis of insulin receptor isoform A and B signaling. Molecular and Cellular Endocrinology 557, pages 111739.
Crossref
Kim G. Jackson, Katie J. Newens, Michael J. Fry, Abby K. Thompson & Christine M. Williams. (2022) Differential effects of single fatty acids and fatty acid mixtures on the phosphoinositide 3-kinase/Akt/eNOS pathway in endothelial cells. European Journal of Nutrition 61:5, pages 2463-2473.
Crossref
Mengwei Li, Xiaowei Chi, Ying Wang, Sarra Setrerrahmane, Wenwei Xie & Hanmei Xu. (2022) Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduction and Targeted Therapy 7:1.
Crossref
Jinyang Cai, Sheeba Jacob, Richard Kurupi, Krista M. Dalton, Colin Coon, Patricia Greninger, Regina K. Egan, Giovanna T. Stein, Ellen Murchie, Joseph McClanaghan, Yuta Adachi, Kentaro Hirade, Mikhail Dozmorov, John Glod, Sosipatros A. Boikos, Hiromichi Ebi, Huaixiang Hao, Giordano Caponigro, Cyril H. Benes & Anthony C. Faber. (2022) High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition. Cell Reports 40:4, pages 111095.
Crossref
Rio Jati Kusuma, Desty Ervira Puspaningtyas & Puspita Mardika Sari. (2022) Effect of fermented cassava tuber on the gene expression of PI3K/Akt signaling and AMPK pathway in STZ-NA-induced diabetic rats. Nutrition & Food Science 52:2, pages 213-224.
Crossref
Giovanni Solinas & Barbara Becattini. 2022. PI3K and AKT Isoforms in Immunity. PI3K and AKT Isoforms in Immunity 311 336 .
Tong-Zhuang Wang, Guo-Wei Zuo, Ling Yao, Chun-Lin Yuan, Hai-Fei Li, Ying Lai, Zhi-Wei Chen, Jun Zhang, Ya-Qian Jin, Johji Yamahara & Jian-Wei Wang. (2021) Ursolic acid ameliorates adipose tissue insulin resistance in aged rats via activating the Akt‑glucose transporter 4 signaling pathway and inhibiting inflammation. Experimental and Therapeutic Medicine 22:6.
Crossref
Eva M. Berghausen, Wiebke Janssen, Marius Vantler, Leoni L. Gnatzy-Feik, Max Krause, Arnica Behringer, Christine Joseph, Mario Zierden, Henrik ten Freyhaus, Anna Klinke, Stephan Baldus, Miguel A. Alcazar, Rajkumar Savai, Soni Savai Pullamsetti, Dickson W.L. Wong, Peter Boor, Jean J. Zhao, Ralph T. Schermuly & Stephan Rosenkranz. (2021) Disrupted PI3K subunit p110α signaling protects against pulmonary hypertension and reverses established disease in rodents. Journal of Clinical Investigation 131:19.
Crossref
Silvia Arcucci, Fernanda Ramos-Delgado, Coralie Cayron, Nicole Therville, Marie-Pierre Gratacap, Céline Basset, Benoit Thibault & Julie Guillermet-Guibert. (2021) Organismal roles for the PI3Kα and β isoforms: their specificity, redundancy or cooperation is context-dependent. Biochemical Journal 478:6, pages 1199-1225.
Crossref
Catríona M. Dowling, Hua Zhang, Tríona Ní Chonghaile & Kwok-Kin Wong. (2021) Shining a light on metabolic vulnerabilities in non-small cell lung cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188462.
Crossref
Paul HolvoetPaul Holvoet. 2021. Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer. Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer 53 72 .
Fei Xu, Lixin Na, Yanfei Li & Linjun Chen. (2020) RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell & Bioscience 10:1.
Crossref
Joy Ujiroghene Obaroakpo, Wenlong Nan, Liyu Hao, Lu Liu, Shuwen Zhang, Jing Lu, Xiaoyang Pang & Jiaping Lv. (2020) The hyperglycemic regulatory effect of sprouted quinoa yoghurt in high-fat-diet and streptozotocin-induced type 2 diabetic mice via glucose and lipid homeostasis . Food & Function 11:9, pages 8354-8368.
Crossref
Mi Wang, Yanjun Mao, Bo Wang, Shanshan Wang, Han Lu, Linlin Ying & Yao Li. (2020) Quercetin Improving Lipid Metabolism by Regulating Lipid Metabolism Pathway of Ileum Mucosa in Broilers. Oxidative Medicine and Cellular Longevity 2020, pages 1-17.
Crossref
Millie FoxHelen R. MottDarerca Owen. (2020) Class IA PI3K regulatory subunits: p110-independent roles and structures. Biochemical Society Transactions 48:4, pages 1397-1417.
Crossref
Benjamin D. Hopkins, Marcus D. Goncalves & Lewis C. Cantley. (2020) Insulin–PI3K signalling: an evolutionarily insulated metabolic driver of cancer. Nature Reviews Endocrinology 16:5, pages 276-283.
Crossref
Jingfan Zhang, Yu Chen, Cong Liu, Ling Li & Ping Li. (2020) N 1 -Methylnicotinamide Improves Hepatic Insulin Sensitivity via Activation of SIRT1 and Inhibition of FOXO1 Acetylation . Journal of Diabetes Research 2020, pages 1-11.
Crossref
Carolina Gutierrez-Repiso, Ailec Ho-Plagaro, Concepción Santiago-Fernandez, Sara Garcia-Serrano, Francisca Rodríguez-Pacheco, Sergio Valdes, Lourdes Garrido-Sanchez, Cristina Rodríguez-Díaz, Carlos López-Gómez, Francisco J. Moreno-Ruiz, Guillermo Alcain-Martinez, Amandine Gautier-Stein, Gilles Mithieux & Eduardo Garcia-Fuentes. (2020) Jejunal Insulin Signalling Is Increased in Morbidly Obese Subjects with High Insulin Resistance and Is Regulated by Insulin and Leptin. Journal of Clinical Medicine 9:1, pages 196.
Crossref
Ralitsa R. Madsen & Bart Vanhaesebroeck. (2020) Cracking the context-specific PI3K signaling code. Science Signaling 13:613.
Crossref
Benjamin Murter & Lawrence P. Kane. (2020) Control of T lymphocyte fate decisions by PI3K signaling. F1000Research 9, pages 1171.
Crossref
Jatin Sharma, Vijay Bhardwaj & Rituraj Purohit. (2019) Structural Perturbations due to Mutation (H1047R) in Phosphoinositide-3-kinase (PI3Kα) and Its Involvement in Oncogenesis: An in Silico Insight. ACS Omega 4:14, pages 15815-15823.
Crossref
Feier Cheng, Lin Han, Yao Xiao, Chuanying Pan, Yunlong Li, Xinhui Ge, Yao Zhang, Shaoqing Yan & Min Wang. (2019) d - chiro -Inositol Ameliorates High Fat Diet-Induced Hepatic Steatosis and Insulin Resistance via PKCε-PI3K/AKT Pathway . Journal of Agricultural and Food Chemistry 67:21, pages 5957-5967.
Crossref
Wenguang Chang, Grant M. Hatch, Yu Wang, Fei Yu & Man Wang. (2019) The relationship between phospholipids and insulin resistance: From clinical to experimental studies. Journal of Cellular and Molecular Medicine 23:2, pages 702-710.
Crossref
Shimin Hu, Shujuan Ma, Xun Li, Zhengwen Tian, Huiling Liang, Junxia Yan, Mengshi Chen & Hongzhuan Tan. (2019) Relationships of SLC2A4 , RBP4 , PCK1, and PI3K Gene Polymorphisms with Gestational Diabetes Mellitus in a Chinese Population . BioMed Research International 2019, pages 1-9.
Crossref
Hsu-Wen Chao, Shi-Wei Chao, Heng Lin, Hui-Chen Ku & Ching-Feng Cheng. (2019) Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 20:2, pages 298.
Crossref
Angelo Maffei, Giuseppe Lembo & Daniela Carnevale. (2018) PI3Kinases in Diabetes Mellitus and Its Related Complications. International Journal of Molecular Sciences 19:12, pages 4098.
Crossref
Xiaoqing Li, Xinxin Li, Genbei Wang, Yan Xu, Yuanyuan Wang, Ruijia Hao & Xiaohui Ma. (2018) Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice. Frontiers of Medicine 12:6, pages 688-696.
Crossref
Marcus D. GoncalvesBenjamin D. HopkinsLewis C. Cantley. (2018) Phosphatidylinositol 3-Kinase, Growth Disorders, and Cancer. New England Journal of Medicine 379:21, pages 2052-2062.
Crossref
Max C. Petersen & Gerald I. Shulman. (2018) Mechanisms of Insulin Action and Insulin Resistance. Physiological Reviews 98:4, pages 2133-2223.
Crossref
Vitor F. Martins, Shahriar Tahvilian, Ji H. Kang, Kristoffer Svensson, Byron Hetrick, Wallace S. Chick, Simon Schenk & Carrie E. McCurdy. (2018) Calorie Restriction-Induced Increase in Skeletal Muscle Insulin Sensitivity Is Not Prevented by Overexpression of the p55α Subunit of Phosphoinositide 3-Kinase. Frontiers in Physiology 9.
Crossref
Apichaya Niyomchan, Daranee Visitnonthachai, Sumitra Suntararuks, Pronrumpa Ngamsiri, Piyajit Watcharasit & Jutamaad Satayavivad. (2018) Arsenic impairs insulin signaling in differentiated neuroblastoma SH-SY5Y cells. NeuroToxicology 66, pages 22-31.
Crossref
Javier T. Gonzalez, Judith D. Richardson, Enhad A. Chowdhury, Francoise Koumanov, Geoffrey D. Holman, Scott Cooper, Dylan Thompson, Kostas Tsintzas & James A. Betts. (2018) Molecular adaptations of adipose tissue to 6 weeks of morning fasting vs. daily breakfast consumption in lean and obese adults. The Journal of Physiology 596:4, pages 609-622.
Crossref
David Garcia-Galiano, Beatriz C. Borges, Jose DonatoJr.Jr., Susan J. Allen, Nicole Bellefontaine, Mengjie Wang, Jean J. Zhao, Kenneth M. Kozloff, Jennifer W. Hill & Carol F. Elias. (2017) PI3Kα inactivation in leptin receptor cells increases leptin sensitivity but disrupts growth and reproduction. JCI Insight 2:23.
Crossref
Zhihua Du & Vladimir Uversky. (2017) A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes. International Journal of Molecular Sciences 18:10, pages 2010.
Crossref
Nina IlicKıvanç BirsoyAndrew J. AguirreNora KoryMichael E. PacoldShambhavi SinghSusan E. MoodyJoseph D. DeAngeloNicole A. SpardyElizaveta FreinkmanBarbara A. WeirAviad Tsherniak, Glenn S. CowleyDavid E. RootJohn M. AsaraFrancisca VazquezHans R. Widlund, David M. SabatiniWilliam C. Hahn. (2017) PIK3CA mutant tumors depend on oxoglutarate dehydrogenase . Proceedings of the National Academy of Sciences 114:17.
Crossref
Ebubekir Dirican & Mustafa Akkiprik. (2017) Phosphatidylinositol 3-kinase regulatory subunit 1 and phosphatase and tensin homolog as therapeutic targets in breast cancer. Tumor Biology 39:3, pages 101042831769552.
Crossref
Aditi Chaudhari, Katarina Ejeskär, Yvonne Wettergren, C. Ronald Kahn & Victoria Rotter Sopasakis. (2018) Hepatic deletion of p110α and p85α results in insulin resistance despite sustained IRS1-associated phosphatidylinositol kinase activity. F1000Research 6, pages 1600.
Crossref
Aditi Chaudhari, Katarina Ejeskär, Yvonne Wettergren, C. Ronald Kahn & Victoria Rotter Sopasakis. (2017) Hepatic deletion of p110α and p85α results in insulin resistance despite sustained IRS1-associated phosphatidylinositol kinase activity. F1000Research 6, pages 1600.
Crossref
Beatriz C. Borges, David Garcia-Galiano, Rodrigo Rorato, Lucila L.K. Elias & Carol F. Elias. (2016) PI3K p110β subunit in leptin receptor expressing cells is required for the acute hypophagia induced by endotoxemia. Molecular Metabolism 5:6, pages 379-391.
Crossref
LI-XU YAN, YAN-HUI LIU, JIAN-WEN XIANG, QI-NIAN WU, LEI-BO XU, XIN-LAN LUO, XIAO-LAN ZHU, CHAO LIU, FANG-PING XU, DONG-LAN LUO, PING MEI, JIE XU, KE-PING ZHANG & JIE CHEN. (2016) PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. International Journal of Oncology 48:2, pages 471-484.
Crossref
Ke Fang, Hui Dong, Shujun Jiang, Fen Li, Dingkun Wang, Desen Yang, Jing Gong, Wenya Huang & Fuer Lu. (2016) Diosgenin and 5-Methoxypsoralen Ameliorate Insulin Resistance through ER- α /PI3K/Akt-Signaling Pathways in HepG2 Cells . Evidence-Based Complementary and Alternative Medicine 2016, pages 1-11.
Crossref
Morris F. White & Kyle D. Copps. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric 556 585.e13 .
Yajuan Qi, Xiaoqin Guo & Shaodong Guo. 2016. Metabolic Syndrome. Metabolic Syndrome 479 504 .
Alfredo Fort, Nicolas Calo, Dorothea Portius, Lucie Bourgoin, Marion Peyrou & Michelangelo Foti. 2015. Signaling Pathways in Liver Diseases. Signaling Pathways in Liver Diseases 287 313 .
Martina Beretta, Michael Bauer & Emilio Hirsch. (2015) PI3K signaling in the pathogenesis of obesity: The cause and the cure. Advances in Biological Regulation 58, pages 1-15.
Crossref
Ana BoschZhiqiang LiAnna BergamaschiHaley EllisEneda ToskaAleix PratJessica J. TaoDaniel E. SprattNerissa T. Viola-VillegasPau CastelGerard MinuesaNatasha MorseJordi RodónYasir IbrahimJavier CortesJose Perez-GarciaPatricia GalvanJudit GruesoMarta GuzmanJohn A. KatzenellenbogenMichael KharasJason S. LewisMaura DicklerVioleta SerraNeal RosenSarat ChandarlapatyMaurizio ScaltritiJosé Baselga. (2015) PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer. Science Translational Medicine 7:283.
Crossref
Dejan Juric, Pau Castel, Malachi Griffith, Obi L. Griffith, Helen H. Won, Haley Ellis, Saya H. Ebbesen, Benjamin J. Ainscough, Avinash Ramu, Gopa Iyer, Ronak H. Shah, Tiffany Huynh, Mari Mino-Kenudson, Dennis Sgroi, Steven Isakoff, Ashraf Thabet, Leila Elamine, David B. Solit, Scott W. Lowe, Cornelia Quadt, Malte Peters, Adnan Derti, Robert Schegel, Alan Huang, Elaine R. Mardis, Michael F. Berger, José Baselga & Maurizio Scaltriti. (2014) Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor. Nature 518:7538, pages 240-244.
Crossref
Yajuan Qi, Xiaoqin Guo & Shaodong Guo. 2014. Metabolic Syndrome. Metabolic Syndrome 1 29 .
Yajuan Qi, Xiaoqin Guo & Shaodong Guo. 2014. Metabolic Syndrome. Metabolic Syndrome 1 29 .
Carrie L. Lucas, Yu Zhang, Anthony Venida, Ying Wang, Jason Hughes, Joshua McElwee, Morgan Butrick, Helen Matthews, Susan Price, Matthew Biancalana, Xiaochuan Wang, Michael Richards, Tamara Pozos, Isil Barlan, Ahmet Ozen, V. Koneti Rao, Helen C. Su & Michael J. Lenardo. (2014) Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K. Journal of Experimental Medicine 211:13, pages 2537-2547.
Crossref
Fa-Cai Li, Robin B Gasser, James B Lok, Pasi K Korhonen, Yi-Fan Wang, Fang-Yuan Yin, Li He, Rui Zhou, Jun-Long Zhao & Min Hu. (2014) Exploring the role of two interacting phosphoinositide 3-kinases of Haemonchus contortus. Parasites & Vectors 7:1.
Crossref
Jason R. Westin. (2014) Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma. Clinical Lymphoma Myeloma and Leukemia 14:5, pages 335-342.
Crossref
Sang Won Park, Hilde Herrema, Mario Salazar, Isin Cakir, Serkan Cabi, Fatma Basibuyuk Sahin, Yu-Hsin Chiu, Lewis C. Cantley & Umut Ozcan. (2014) BRD7 Regulates XBP1s’ Activity and Glucose Homeostasis through Its Interaction with the Regulatory Subunits of PI3K. Cell Metabolism 20:1, pages 73-84.
Crossref
Shaodong Guo. (2014) Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms. Journal of Endocrinology 220:2, pages T1-T23.
Crossref
Shervi LieJanna L. MorrisonOlivia Williams-WyssSusan E. OzanneSong ZhangSimon K. Walker, David O. Kleemann, Severence M. MacLaughlinClaire T. Roberts & I. Caroline McMillen. (2013) Impact of embryo number and periconceptional undernutrition on factors regulating adipogenesis, lipogenesis, and metabolism in adipose tissuein the sheep fetus. American Journal of Physiology-Endocrinology and Metabolism 305:8, pages E931-E941.
Crossref
Moshe ElkabetsSadhna VoraDejan JuricNatasha MorseMari Mino-KenudsonTaru MuranenJessica TaoAna Bosch CamposJordi RodonYasir H. IbrahimVioleta SerraVanessa Rodrik-OutmezguineSaswati HazraSharat SinghPhillip KimCornelia QuadtManway LiuAlan HuangNeal RosenJeffrey A. EngelmanMaurizio ScaltritiJosé Baselga. (2013) mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in PIK3CA -Mutant Breast Cancer . Science Translational Medicine 5:196.
Crossref
Kostas TsintzasLuke NortonKamal ChokkalingamNusrat NizamaniScott CooperFrancis StephensRudolf BilleterAndrew Bennett. (2013) Independent and combined effects of acute physiological hyperglycaemia and hyperinsulinaemia on metabolic gene expression in human skeletal muscle. Clinical Science 124:11, pages 675-686.
Crossref
J. Kolic, A. F. Spigelman, G. Plummer, E. Leung, C. Hajmrle, T. Kin, A. M. J. Shapiro, J. E. Manning Fox & P. E. MacDonald. (2013) Distinct and opposing roles for the phosphatidylinositol 3-OH kinase catalytic subunits p110α and p110β in the regulation of insulin secretion from rodent and human beta cells. Diabetologia 56:6, pages 1339-1349.
Crossref
Robert D. Riehle, Sinziana Cornea & Alexei Degterev. 2013. Lipid-mediated Protein Signaling. Lipid-mediated Protein Signaling 105 139 .
Beatrix Bartok, David L. Boyle, Yi Liu, Pingda Ren, Scott T. Ball, William D. Bugbee, Christian Rommel & Gary S. Firestein. (2012) PI3 Kinase δ Is a Key Regulator of Synoviocyte Function in Rheumatoid Arthritis. The American Journal of Pathology 180:5, pages 1906-1916.
Crossref
Paul Mellor, Levi A. Furber, Jennifer N. K. Nyarko & Deborah H. Anderson. (2011) Multiple roles for the p85α isoform in the regulation and function of PI3K signalling and receptor trafficking. Biochemical Journal 441:1, pages 23-37.
Crossref
Alessandra Ghigo, Fulvio Morello, Alessia Perino & Emilio Hirsch. 2012. Phosphoinositides I: Enzymes of Synthesis and Degradation. Phosphoinositides I: Enzymes of Synthesis and Degradation 183 213 .
Susmita Ghosh, Hiu Lau, Brian W. Simons, Jonathan D. Powell, David J. Meyers, Angelo M. De Marzo, David M. Berman & Tamara L. Lotan. (2011) PI3K/mTOR signaling regulates prostatic branching morphogenesis. Developmental Biology 360:2, pages 329-342.
Crossref
Anna Wojtalla & Alexandre Arcaro. (2011) Targeting phosphoinositide 3-kinase signalling in lung cancer. Critical Reviews in Oncology/Hematology 80:2, pages 278-290.
Crossref
Susan E. Ozanne & Kenneth Siddle. 2011. The Metabolic Syndrome. The Metabolic Syndrome 60 80 .
Nissim Hay. (2011) Akt isoforms and glucose homeostasis – the leptin connection. Trends in Endocrinology & Metabolism 22:2, pages 66-73.
Crossref
Tina L. Yuan, Gerburg Wulf, Laura Burga & Lewis C. Cantley. (2011) Cell-to-Cell Variability in PI3K Protein Level Regulates PI3K-AKT Pathway Activity in Cell Populations. Current Biology 21:3, pages 173-183.
Crossref
Sandra Pereira & Adria Giacca. 2011. Insulin Resistance and Cancer. Insulin Resistance and Cancer 1 52 .
Sudha B. Biddinger & Brice Emanuelli. 2011. Metabolic Basis of Obesity. Metabolic Basis of Obesity 175 198 .
Elisabeth FayardGerald MoncayoBrian A. HemmingsGeorg A. Holländer. (2010) Phosphatidylinositol 3-Kinase Signaling in Thymocytes: The Need for Stringent Control. Science Signaling 3:135.
Crossref
A. Tups, G. M. Anderson, M. Rizwan, R. A. Augustine, C. Chaussade, P. R. Shepherd & D. R. Grattan. (2010) Both p110α and p110β Isoforms of Phosphatidylinositol 3-OH-Kinase are Required for Insulin Signalling in the Hypothalamus. Journal of Neuroendocrinology 22:6, pages 534-542.
Crossref
Rasmus Ribel-MadsenPernille PoulsenJohan HolmkvistBrynjulf MortensenNiels GrarupMartin FriedrichsenTorben JørgensenTorsten LauritzenJørgen F.P. WojtaszewskiOluf PedersenTorben HansenAllan Vaag. (2010) Impact of rs361072 in the Phosphoinositide 3-Kinase p110β Gene on Whole-Body Glucose Metabolism and Subunit Protein Expression in Skeletal Muscle. Diabetes 59:4, pages 1108-1112.
Crossref
Jonathon N Winnay, Jeremie Boucher, Marcelo A Mori, Kohjiro Ueki & C Ronald Kahn. (2010) A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box–binding protein-1 to modulate the unfolded protein response. Nature Medicine 16:4, pages 438-445.
Crossref
R W MathenyJrJr & M L Adamo. (2009) PI3K p110α and p110β have differential effects on Akt activation and protection against oxidative stress-induced apoptosis in myoblasts. Cell Death & Differentiation 17:4, pages 677-688.
Crossref
Ryaz B. Chagpar, Philip H. Links, M. Chris Pastor, Levi A. Furber, Andrea D. Hawrysh, M. Dean Chamberlain & Deborah H. Anderson. (2010) Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Proceedings of the National Academy of Sciences 107:12, pages 5471-5476.
Crossref
Valérie MartinJulie Guillermet-GuibertGaétan ChicanneCendrine Cabou, Martine Jandrot-Perrus, Monique PlantavidBart VanhaesebroeckBernard PayrastreMarie-Pierre Gratacap. (2010) Deletion of the p110β isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood 115:10, pages 2008-2013.
Crossref
Victoria Rotter Sopasakis, Pixu Liu, Ryo Suzuki, Tatsuya Kondo, Jonathon Winnay, Thien T. Tran, Tomoichiro Asano, Graham Smyth, Mini P. Sajan, Robert V. Farese, C. Ronald Kahn & Jean J. Zhao. (2010) Specific Roles of the p110α Isoform of Phosphatidylinsositol 3-Kinase in Hepatic Insulin Signaling and Metabolic Regulation. Cell Metabolism 11:3, pages 220-230.
Crossref
Maud Kamal, Andre Pawlak, Fatima BenMohamed, Asta Valanciuté, Karine Dahan, Marina Candelier, Philippe Lang, Georges Guellaën & Djillali Sahali. (2010) C-mip interacts with the p85 subunit of PI3 kinase and exerts a dual effect on ERK signaling via the recruitment of Dip1 and DAP kinase. FEBS Letters 584:3, pages 500-506.
Crossref
Raju V.S Rajala. (2010) Phosphoinositide 3-kinase signaling in the vertebrate retina. Journal of Lipid Research 51:1, pages 4-22.
Crossref
Morris F. White, Kyle D. Copps, Umut Ozcan & Yolanda Tseng. 2010. Endocrinology. Endocrinology 636 659 .
Carrie E. McCurdy & Jacob E. Friedman. 2010. Gestational Diabetes During and After Pregnancy. Gestational Diabetes During and After Pregnancy 125 138 .
Nina Ilić & Thomas M. Roberts. 2011. Phosphoinositide 3-kinase in Health and Disease. Phosphoinositide 3-kinase in Health and Disease 55 77 .
Jonathan M. Backer. 2011. Phosphoinositide 3-kinase in Health and Disease. Phosphoinositide 3-kinase in Health and Disease 87 114 .
Takehiko Sasaki, Shunsuke Takasuga, Junko Sasaki, Satoshi Kofuji, Satoshi Eguchi, Masakazu Yamazaki & Akira Suzuki. (2009) Mammalian phosphoinositide kinases and phosphatases. Progress in Lipid Research 48:6, pages 307-343.
Crossref
Shih-Min A. Huang, Michael K. Hancock, Jeffrey L. Pitman, Anthony P. Orth & Nicholas Gekakis. (2009) Negative Regulators of Insulin Signaling Revealed in a Genome-Wide Functional Screen. PLoS ONE 4:9, pages e6871.
Crossref
Pixu Liu, Hailing Cheng, Thomas M. Roberts & Jean J. Zhao. (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nature Reviews Drug Discovery 8:8, pages 627-644.
Crossref
Thomas BohnackerRomina MaroneEmilie CollmannRonan CalvezEmilio HirschMatthias P. Wymann. (2009) PI3Kγ Adaptor Subunits Define Coupling to Degranulation and Cell Motility by Distinct PtdIns(3,4,5)P 3 Pools in Mast Cells . Science Signaling 2:74.
Crossref
Jenn-Yah YuSteven H. ReynoldsSteve D. HatfieldHalyna R. ShcherbataKarin A. FischerEllen J. WardDang LongYe DingHannele Ruohola-Baker. (2009) Dicer-1-dependent Dacapo suppression acts downstream of Insulin receptor in regulating cell division of Drosophila germline stem cells . Development 136:9, pages 1497-1507.
Crossref
Brian S. Schaffhausen & Thomas M. Roberts. (2009) Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer. Virology 384:2, pages 304-316.
Crossref
John Papaconstantinou. (2009) Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination. Molecular and Cellular Endocrinology 299:1, pages 89-100.
Crossref
Christine K. Cheng, Qi-Wen Fan & William A. Weiss. (2009) PI3K Signaling in Glioma-Animal Models and Therapeutic Challenges. Brain Pathology 19:1, pages 112-120.
Crossref
Frank KuhnertMichael R. MancusoJessica HamptonKryn StankunasTomoichiro AsanoChang-Zheng ChenCalvin J. Kuo. (2008) Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126 . Development 135:24, pages 3989-3993.
Crossref
Jeffrey A Engelman, Liang Chen, Xiaohong Tan, Katherine Crosby, Alexander R Guimaraes, Rabi Upadhyay, Michel Maira, Kate McNamara, Samanthi A Perera, Youngchul Song, Lucian R Chirieac, Ramneet Kaur, Angela Lightbown, Jessica Simendinger, Timothy Li, Robert F Padera, Carlos García-Echeverría, Ralph Weissleder, Umar Mahmood, Lewis C Cantley & Kwok-Kin Wong. (2008) Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nature Medicine 14:12, pages 1351-1356.
Crossref
Oliver Renner, Carmen Blanco-Aparicio & Amancio Carnero. (2008) Genetic modelling of the PTEN/AKT pathway in cancer research. Clinical and Translational Oncology 10:10, pages 618-627.
Crossref
Vijayalakshmi Nandakumar, Trygve Tollefsbol, Ada Elgavish & Sabita Saldanha. 2008. Cancer Epigenetics. Cancer Epigenetics 197 214 .
Elisa CiraoloManuela IezziRomina MaroneStefano MarengoClaudia CurcioCarlotta CostaOrnella AzzolinoCristiano GonellaCristina RubinettoHaiyan WuWalter DastrùErica L. MartinLorenzo SilengoFiorella AltrudaEmilia TurcoLetizia LanzettiPiero MusianiThomas RückleChristian RommelJonathan M. BackerGuido ForniMatthias P. WymannEmilio Hirsch. (2008) Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development. Science Signaling 1:36.
Crossref
Adam J. Shaywitz, Kevin D. Courtney, Akash Patnaik & Lewis C. Cantley. (2008) PI3K Enters Beta-Testing. Cell Metabolism 8:3, pages 179-181.
Crossref
Shidong Jia, Zhenning Liu, Sen Zhang, Pixu Liu, Lei Zhang, Sang Hyun Lee, Jing Zhang, Sabina Signoretti, Massimo Loda, Thomas M. Roberts & Jean J. Zhao. (2008) Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis. Nature 454:7205, pages 776-779.
Crossref
Nicolas Molnarfi, Karim J. Brandt, Lyssia Gruaz, Jean-Michel Dayer & Danielle Burger. (2008) Differential regulation of cytokine production by PI3Kδ in human monocytes upon acute and chronic inflammatory conditions. Molecular Immunology 45:12, pages 3419-3427.
Crossref
Julie Guillermet-GuibertKatja BjorklofAshreena SalpekarCristiano GonellaFaruk Ramadani, Antonio BilancioStephen Meek, Andrew J. H. Smith, Klaus Okkenhaug & Bart Vanhaesebroeck. (2008) The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ. Proceedings of the National Academy of Sciences 105:24, pages 8292-8297.
Crossref
Emilio Hirsch, Elisa Ciraolo, Alessandra Ghigo & Carlotta Costa. (2008) Taming the PI3K team to hold inflammation and cancer at bay. Pharmacology & Therapeutics 118:2, pages 192-205.
Crossref
Hiroaki Watanabe, Hiroshi Saito, Junji Ueda & B. Mark Evers. (2008) Regulation of pancreatic duct cell differentiation by phosphatidylinositol-3 kinase. Biochemical and Biophysical Research Communications 370:1, pages 33-37.
Crossref
Bin Wu, Xiaoyan Liu & Jinfang Shen. (2008) Old biliverdin reductase: Links to insulin resistance and may be a novel therapeutic target. Medical Hypotheses 71:1, pages 73-76.
Crossref
Ping WangPuneet KumarChang WangKathryn A. DeFea. (2007) Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110α and β by protease-activated receptor 2 and β-arrestins. Biochemical Journal 408:2, pages 221-230.
Crossref
Donald G. Robertson, Kaushik Datta, Dale Wells, Laura Egnash, Lora Robosky, Matt Manning, Cynthia Rohde & Michael D. Reily. (2007) Metabonomic Evaluation of Metabolic Dysregulation in Rats Induced by PF 376304, a Novel Inhibitor of Phosphoinositide 3-Kinase. Chemical Research in Toxicology 20:12, pages 1871-1877.
Crossref
David A. Medina-Tato, Stephen G. Ward & Malcolm L. Watson. (2007) Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond. Immunology 121:4, pages 448-461.
Crossref
Claire Chaussade, Gordon W. Rewcastle, Jackie D. Kendall, William A. Denny, Kitty Cho, Line M. Grønning, Mei Ling Chong, Sasha H. Anagnostou, Shaun P. Jackson, Nathalie Daniele & Peter R. Shepherd. (2007) Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochemical Journal 404:3, pages 449-458.
Crossref
James D. ChangGalina K. SukhovaPeter LibbyEugenia SchvartzAlice H. LichtensteinSeth J. Field, Caitlin KennedySwetha MadhavarapuJi LuoDianqing Wu & Lewis C. Cantley. (2007) Deletion of the phosphoinositide 3-kinase p110γ gene attenuates murine atherosclerosis. Proceedings of the National Academy of Sciences 104:19, pages 8077-8082.
Crossref
Barbara Geering, Pedro R. Cutillas, Gemma Nock, Severine I. Gharbi & Bart Vanhaesebroeck. (2007) Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Proceedings of the National Academy of Sciences 104:19, pages 7809-7814.
Crossref
B. GeeringP.R. CutillasB. Vanhaesebroeck. (2007) Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits?. Biochemical Society Transactions 35:2, pages 199-203.
Crossref
Zachary A. Knight & Kevan M. Shokat. (2007) Chemical Genetics: Where Genetics and Pharmacology Meet. Cell 128:3, pages 425-430.
Crossref
Jean J. ZhaoThomas M. Roberts. (2006) PI3 Kinases in Cancer: From Oncogene Artifact to Leading Cancer Target. Science's STKE 2006:365.
Crossref
Jean J. Zhao, Hailing Cheng, Shidong Jia, Li Wang, Ole V. Gjoerup, Aki Mikami & Thomas M. Roberts. (2006) The p110α isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation. Proceedings of the National Academy of Sciences 103:44, pages 16296-16300.
Crossref
Jeffrey A. Engelman, Ji Luo & Lewis C. Cantley. (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nature Reviews Genetics 7:8, pages 606-619.
Crossref
Joan K Riley & Kelle H Moley. (2006) Glucose utilization and the PI3-K pathway: mechanisms for cell survival in preimplantation embryos. Reproduction 131:5, pages 823-835.
Crossref
Lazaros C. Foukas, Marc Claret, Wayne Pearce, Klaus Okkenhaug, Stephen Meek, Emma Peskett, Sara Sancho, Andrew J. H. Smith, Dominic J. Withers & Bart Vanhaesebroeck. (2006) Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441:7091, pages 366-370.
Crossref
Julian A. Simon. (2006) Using Isoform-Specific Inhibitors to Target Lipid Kinases. Cell 125:4, pages 647-649.
Crossref
Zachary A. Knight, Beatriz Gonzalez, Morri E. Feldman, Eli R. Zunder, David D. Goldenberg, Olusegun Williams, Robbie Loewith, David Stokoe, Andras Balla, Balazs Toth, Tamas Balla, William A. Weiss, Roger L. Williams & Kevan M. Shokat. (2006) A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling. Cell 125:4, pages 733-747.
Crossref
Qi-Wen Fan, Zachary A. Knight, David D. Goldenberg, Wei Yu, Keith E. Mostov, David Stokoe, Kevan M. Shokat & William A. Weiss. (2006) A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell 9:5, pages 341-349.
Crossref
Caroline Pendaries, Hélène Tronchère, Laurence Arbibe, Joelle Mounier, Or Gozani, Lewis Cantley, Michael J Fry, Frédérique Gaits-Iacovoni, Philippe J Sansonetti & Bernard Payrastre. (2006) PtdIns(5)P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection. The EMBO Journal 25:5, pages 1024-1034.
Crossref
Chihiro Tohda, Ruiko Nakanishi & Makoto Kadowaki. (2006) Learning Deficits and Agenesis of Synapses and Myelinated Axons in Phosphoinositide-3 Kinase-Deficient Mice. Neurosignals 15:6, pages 293-306.
Crossref
Sudha B. Biddinger & C. Ronald Kahn. (2006) FROM MICE TO MEN: Insights into the Insulin Resistance Syndromes. Annual Review of Physiology 68:1, pages 123-158.
Crossref
N. Neubauer & R. N. Kulkarni. (2006) Molecular Approaches to Study Control of Glucose Homeostasis. ILAR Journal 47:3, pages 199-211.
Crossref
Bryan T. Hennessy, Debra L. Smith, Prahlad T. Ram, Yiling Lu & Gordon B. Mills. (2005) Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery. Nature Reviews Drug Discovery 4:12, pages 988-1004.
Crossref
Fernando P. Dominici, Danila P. Argentino, Marina C. Muñoz, Johanna G. Miquet, Ana I. Sotelo & Daniel Turyn. (2005) Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity. Growth Hormone & IGF Research 15:5, pages 324-336.
Crossref
Gautam K. Bandyopadhyay, Joseph G. Yu, Jachelle Ofrecio & Jerold M. Olefsky. (2005) Increased p85/55/50 Expression and Decreased Phosphotidylinositol 3-Kinase Activity in Insulin-Resistant Human Skeletal Muscle. Diabetes 54:8, pages 2351-2359.
Crossref
Ji Luo, Seth J. Field, Jennifer Y. Lee, Jeffrey A. Engelman & Lewis C. Cantley. (2005) The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. Journal of Cell Biology 170:3, pages 455-464.
Crossref
Ji Luo, Cassandra L. Sobkiw, Nicole M. Logsdon, John M. Watt, Sabina Signoretti, Fionnuala O'Connell, Eyoung Shin, Youngju Shim, Lily Pao, Benjamin G. Neel, Ronald A. DePinho, Massimo Loda & Lewis C. Cantley. (2005) Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN +/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase . Proceedings of the National Academy of Sciences 102:29, pages 10238-10243.
Crossref
Louise Chang, Shian-Huey Chiang & Alan R Saltiel. (2005) Insulin Signaling and the Regulation of Glucose Transport. Molecular Medicine 10:7-12, pages 65-71.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.